NRSA Training Core

NRSA 培训核心

基本信息

项目摘要

The Michigan Institute for Clinical & Health Research (MICHR) recognizes the need for a highly skilled, diverse workforce that can conduct impactful clinical and translational research that improves health. Since the inception of MICHR, the development of a diverse translational workforce has been a consistent priority. This priority includes engaging pre-doctoral trainees within their first few years of training and providing direct experience partnered with specific didactic training. Developed over the course of a decade, our current TL1- supported training programs include a short-term component (Summer Immersion Program) and a long-term component (the Master of Science in Clinical Research Program [MSCR]). This proposal requests support for 10 short-term trainees and 10 long-term trainees (an increase of one trainee) each year. Trainees will comprise a mixture of pre-professional doctoral students (e.g., medical student) and post-professional degree trainees. Other goals include: 1. Providing more opportunities for TL1 trainees to participate in community based research. 2. Supporting trainee career development by formally educating faculty mentors on mentoring skills using the curricula from the National Research Mentoring Network. 3. Expanding the network supporting the development of MSCR trainees. 4. Providing more intern/externship experiences for TL1 trainees. 5. Developing, demonstrating, and disseminating competency-based assessments for all TL1 trainees to improve the measurement of translational research skills. These five key goals will allow the MICHR TL1 programs to effectively train the next generation of translational scientists. The goal is that, upon program completion, these trainees will be highly engaged and motivated to continue work in clinical and translational research, competent in the skills necessary for clinical-translational research, experienced members of multidisciplinary or interprofessional teams led by highly skilled and engaged mentors, and nuanced in their capability to successfully participate in community based research.
密歇根临床与健康研究所(MICHR)认识到需要一个高技能,多样化的

项目成果

期刊论文数量(59)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiac Transitional Care Effectiveness: Does Overall Comorbidity Burden Matter?
  • DOI:
    10.1016/j.amjmed.2021.06.018
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Garfein J;Cholack G;Krallman R;Feldeisen D;Montgomery D;Kline-Rogers E;Eagle K;Rubenfire M;Bumpus S
  • 通讯作者:
    Bumpus S
A Rare Case Report of Neurological Condition: Moersch-Woltman Syndrome with Positive Anti-GAD Antibodies.
神经系统疾病罕见病例报告:抗 GAD 抗体呈阳性的 Moersch-Woltman 综合征。
Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway.
与视交叉后视觉通路病变相关的视野缺陷模式。
Content generation for patient-reported outcome measures for retinal degeneration therapeutic trials.
  • DOI:
    10.1080/13816810.2020.1776337
  • 发表时间:
    2020-08
  • 期刊:
  • 影响因子:
    1.2
  • 作者:
    Lacy GD;Abalem MF;Popova LT;Santos EP;Yu G;Rakine HY;Rosenthal JM;Ehrlich JR;Musch DC;Jayasundera KT
  • 通讯作者:
    Jayasundera KT
A striking presentation of pustular Sweet syndrome induced by trimethoprim-sulfamethoxazole.
  • DOI:
    10.1111/ajd.13897
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Ryder, C. Yoonhee;Matthews, Natalie H.;Lowe, Lori;Wang, Frank
  • 通讯作者:
    Wang, Frank
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL Allan HOLINSTAT其他文献

MICHAEL Allan HOLINSTAT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL Allan HOLINSTAT', 18)}}的其他基金

2022 Midwest Platelet Conference
2022年中西部血小板会议
  • 批准号:
    10536072
  • 财政年份:
    2022
  • 资助金额:
    $ 56.83万
  • 项目类别:
Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
12-脂氧合酶抑制的生物标志物作为肝素诱导的血小板减少症和血栓形成的治疗干预措施 (HIT/T)
  • 批准号:
    10427382
  • 财政年份:
    2021
  • 资助金额:
    $ 56.83万
  • 项目类别:
Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
12-脂氧合酶抑制的生物标志物作为肝素诱导的血小板减少症和血栓形成的治疗干预措施 (HIT/T)
  • 批准号:
    10177358
  • 财政年份:
    2021
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    10728385
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    10590459
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    10599220
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    9902471
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    10372074
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    10319403
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
12-HETrE 对凝血、止血和血栓形成的调节
  • 批准号:
    10474068
  • 财政年份:
    2019
  • 资助金额:
    $ 56.83万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.83万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 56.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了